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Human SOX9 mutations cause the skeletal malformation syndrome campomelic dysplasia 
(CD). Complete inactivation of the Sox9 gene in mice results in failure of cartilage formation. 
Studies in zebrafish and Xenopus suggest that Sox9 may be crucial for specification of the 
otic placode. In mice,  loss of Sox9 results in failure of otic placode invagination.  
Heterozygous mutations in human SOX9 result in conductive and sensorineural deafness in 
some CD patients, implying a later morphogenetic role but phenotypic details are limited. 
Sox9-/- null mice die before morphogenesis of the inner ear is complete, precluding 
investigation of the role of Sox9 later in ear development.  Because all the SOX9 mutations are 
heterozygous and appear to cause loss of function, the CD phenotype has been attributed to 
haploinsufficency of SOX9. However SOX9 proteins containing an intact HMG box and a 
truncated activation domain may act dominant negatively by competition with the wild-type 
for binding to target genes and interfere with interaction with partner factors via the 
transactivation domain.  To assess whether such mutations in SOX9 may act via a  dominant 
interference mechanism we generated transgenic and conditional knock’in mice expressing a 
mouse equivalent of a CD mutation, a Y440X nonsense mutation causing premature 
termination within the trans-activation domain of SOX9 (Sox9Y440X). We compared the 
phenotypic impact of the Sox9Y440X mutation with a Sox9 null mutation. These studies point to an 
essential role for Sox9 in inner ear and intervertebral disc development and context dependent 
mechanisms for the Y440X nonsense mutation.  
